Virtual Total Agilent Experience 2021 - Day 2

Virtual Total Agilent Experience 2021 - Day 2

The symposium will feature innovative analytical technologies, expert talks on emerging trends in food, pharma and biopharma industries, and 1-to-1 interactions with our technical team.
Virtual Total Agilent Experience 2021 - Day 2
Robustness and Ruggedness studies in Method development – Insights and Regulations

Robustness and Ruggedness studies in Method development – Insights and Regulations

Being a reliable partner for your lab, we endeavor to continue providing you ROBUST analytical power to deliver HIGH EFFICIENCY to enhance your PRODUCTIVITY & PROFITABILITY.
Robustness and Ruggedness studies in Method development – Insights and Regulations
Drugs of Abuse Automated Screening vs Manual Testing: What are the Benefits?

Drugs of Abuse Automated Screening vs Manual Testing: What are the Benefits?

In this webinar, learn all about the trends of the Drugs of Abuse as a global problem and the essential factors to consider when starting Drugs of Abuse Testing.
Drugs of Abuse Automated Screening vs Manual Testing: What are the Benefits?
Virtual Total Agilent Experience 2021 - Day 1

Virtual Total Agilent Experience 2021 - Day 1

The symposium will feature innovative analytical technologies, expert talks on emerging trends in food, pharma and biopharma industries, and 1-to-1 interactions with our technical team.
Virtual Total Agilent Experience 2021 - Day 1
High Resolution Size Exclusion Chromatography (SEC) Analysis of Intact Protein Biotherapeutics

High Resolution Size Exclusion Chromatography (SEC) Analysis of Intact Protein Biotherapeutics

This presentation will highlight comprehensive workflows for the analytical characterization of proteins using SEC, ProA-SEC 2D-LC and SEC-MS.
High Resolution Size Exclusion Chromatography (SEC) Analysis of Intact Protein Biotherapeutics
The power of (U)HPLC selectivity for diverse pharmaceutical methods

The power of (U)HPLC selectivity for diverse pharmaceutical methods

With so much attention paid over the years to column efficiency, it is important not forget about the power of selectivity.
The power of (U)HPLC selectivity for diverse pharmaceutical methods
Advances in Proteomics & Metabolomics 2021

Advances in Proteomics & Metabolomics 2021

This event features a collection of exclusive talks from leading scientists in the field, discussing their research and lending insights on the advances and challenges in this exciting space.
Advances in Proteomics & Metabolomics 2021
High-throughput screening symposium - Day 2

High-throughput screening symposium - Day 2

This is your chance to hear first-hand from industry leaders who are revolutionizing high-throughput quantitative analysis using Acoustic Ejection Mass Spectrometry (AEMS).
High-throughput screening symposium - Day 2
Automated workflow for mRNA sequencing by High Resolution LCMS

Automated workflow for mRNA sequencing by High Resolution LCMS

In this webinar we will discuss the use of an automated workflow which includes enzymatic digestion, high resolution LCMS analysis, and data analysis for mRNA sequencing.
Automated workflow for mRNA sequencing by High Resolution LCMS
Determination of Dimethylamine and Nitrite in Pharmaceuticals by Ion Chromatography to Assess the Likelihood of Nitrosamine Formation

Determination of Dimethylamine and Nitrite in Pharmaceuticals by Ion Chromatography to Assess the Likelihood of Nitrosamine Formation

The developed methods should be useful for the rapid screening and quantification of nitrite and DMA in pharmaceuticals and in-process sample to assess the likelihood of NDMA formation.
Determination of Dimethylamine and Nitrite in Pharmaceuticals by Ion Chromatography to Assess the Likelihood of Nitrosamine Formation